Bennett J, Done J, Hunt B
J Psychiatr Ment Health Nurs. 1995;2(3):177-82. doi: 10.1111/j.1365-2850.1995.tb00053.x.
The provision of community-based care for people with serious and enduring mental health problems requires an approach that combines drug therapy, psychological interventions and skills training. Mental health nurses are being required to place more emphasis on their work with this client group. It has been suggested that community psychiatric nurses (CPNs) will require training in appropriate skills to work with the seriously mentally ill. While the training of CPNs to use psychological intervention strategies has received limited attention, the area of medication management, including the detection of side-effects, is relatively unexplored. Community psychiatric nurses' practice with clients on antipsychotic medication was investigated. This paper reports selected findings on the assessment of medication side-effects and CPNs' attitude to this aspect of their role. Fifty CPNs in three health districts completed a self-administered questionnaire. The results showed that the CPNs were supervising the medication of large numbers of clients. They reported that their training had adequately prepared them to assess clients for medication side-effects and that this was being done frequently. They also felt that their reports of side-effects influence the prescribers' decisions on medication when clients are reviewed. However, the data also suggested that CPNs were only monitoring their clients for three to four side-effects and that they held an unfavourable attitude towards their involvement with medication.
为患有严重且持续性心理健康问题的人群提供基于社区的护理，需要一种将药物治疗、心理干预和技能培训相结合的方法。心理健康护士被要求更加重视与这一客户群体的工作。有人建议社区精神科护士（CPN）需要接受适当的技能培训，以便与严重精神疾病患者合作。虽然对CPN进行心理干预策略培训受到的关注有限，但药物管理领域，包括副作用的检测，相对来说尚未得到充分探索。对社区精神科护士在抗精神病药物治疗方面与患者的实践进行了调查。本文报告了在药物副作用评估以及CPN对其角色这一方面的态度方面的部分研究结果。三个健康区的50名CPN完成了一份自填式问卷。结果显示，CPN正在监督大量患者的用药情况。他们报告称，他们所接受的培训使他们有足够的能力评估患者的药物副作用，而且他们经常这样做。他们还认为，在对患者进行复查时，他们关于副作用的报告影响了开药者的用药决定。然而，数据也表明，CPN只监测患者的三到四种副作用，而且他们对自己参与药物管理持不利态度。
